Ophthalmologists, meet LACRIFILL® Canalicular Gel, the essential new addition to your clinical practice.
Are your patients struggling with dry eye after surgery and not finding daily eye drops helpful? Are punctal plugs not providing the relief they need, and are they returning with complaints about discomfort, dislodging, even infection?
LACRIFILL® Canalicular Gel is a new intervention that can help you treat dry eye before and after cataract, glaucoma and other refractive surgeries. It also can help patients with dry eye symptoms, whatever the cause, that aren’t relieved by other therapies. This proprietary, novel cross-linked Hyaluronic Acid gel is used to fill the lacrimal caniculi so that patient’s eyes are bathed in their own natural tears.
75%
of patients had dry eye prior to cataract surgery
Trattler WB, Majmudar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF, The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye, Clinical Ophthalmology, 7 August 2017
37.4%
of patients without dry eye developed dry eye after cataract surgery
Miura Prevalence and Characteristics of Dry Eye Disease After Cataract Surgery- A Systematic Review and Meta-Analysis. Ophthalmol Ther, 2022
28%
had symptoms of dry eye at 3 months after LASIK
Eydelman Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies JAMA Oph, 2016
Optometrists, meet LACRIFILL, a revolutionary way to help your patients with dry eye.
Every week, you’re likely seeing patients who suffer with dry eye, whether due to certain medical conditions, aging, or contact lenses. Using eye drops is burdensome, and artificial tears can’t replace real tears. And many patients struggle with punctal plugs, which can cause discomfort, fall out, or lead to infection.
LACRIFILL is a new intervention that can help most of your patients with dry eye, especially those who can’t tolerate their contact lenses. This proprietary, novel cross-linked Hyaluronic Acid gel is used to fill the lacrimal caniculi so that patient’s eyes are bathed in their own natural tears.
79%
prevalence of dry eye symptoms in perimenopausal and postmenopausal women
Garcia-Alfaro P, Garcia S, Rodriguez I, Vergés C Dry Eye disease symptoms an duality of life in perimenopausal and postmenopausal; women, Climacteric. 2021 Jun;24(3):261-266. doi: 10.1080/13697137.2020.1849087. Epub 2020 Dec 7.PMID: 33283560
79%
of contact lens wearers reported symptoms of dry eye
Begley, Carolyn G. O.D., M.S.; Chalmers, Robin L. O.D.; Mitchell, G. Lynn M.A.S.; Nichols, Kelly K. O.D., M.P.H., Ph.D.; Caffery, Barbara O.D., M.S.; Simpson, Trefford Ph.D.; DuToit, Renee Mphil.Optom.; Portello, Joan O.D., M.P.H.; Davis, Larry O.D. Characterization of Ocular Surface Symptoms From Optometric Practices in North America, Cornea 20(6):p 610-618, August 2001.
This is dry eye treatment, reinvented.
LACRIFILL® Canalicular Gel is…
A Novel Care Option
For patients whose symptoms of dry eye persist despite the use of alternative therapies.
- Non-inferior to the Oasis plug based on Schirmer Test and OSDI at 3 months
- Statistically significant improvements from baseline in Schirmer, corneal staining, tear breakup time and OSDI at both 3 months and 6 months
- Trend towards better maintenance of the corneal surface compared to Oasis (stable vs. increasing staining at 6 months)
Easy to Administer
During an office visit as a one-size-fits-all, gel-based lacrimal filler.
Market Ready
Cleared for use by the U.S. FDA., based on the results of clinical studies.
Favorable Reimbursement
Using CPT Code 68761, benefiting your practice as it benefits your patients. One pre-filled LACRIFILL injector can fill both the upper and lower canaliculi.
Comfortable for Patients
It eliminates the risks of currently available punctal plugs, such as premature loss, dislodgement, infection, irritation, and rubbing. If it needs to be removed, simple irrigation does the trick.
Long Lasting
LACRIFILL Canalicular Gel provides relief for six months at a time.
CONTRAINDICATIONS
LACRIFILL is contraindicated for patients experiencing epiphora, inflammation of the eye lid, and tearing secondary to dacryocystitis with mucopurulent discharge and any other active ocular or periocular infection, those who are allergic to hyaluronic acid or to the specific device material, and those who have known lacrimal outflow obstruction.
Upcoming Tradeshows
ASCRS
April 4–5, 2024 | Boston, MA
Booth #1245